Ignite Creation Date:
2025-12-24 @ 9:54 PM
Ignite Modification Date:
2026-01-05 @ 5:40 PM
Study NCT ID:
NCT06181032
Status:
RECRUITING
Last Update Posted:
2024-04-30
First Post:
2023-11-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Adebrelimab in Combination With Apatinib Gemcitabine and Cisplatin in Biliary Tract Malignancies
Sponsor:
First Affiliated Hospital of Fujian Medical University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
23-OBU-FJ-BTC-II-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None